1. Notification No. 2. Notification of Director of Pharmaceuticals and Cosmetics Division I, Director of Safety Division and Director of Biologics and Antibiotics Division, Pharmaceutical Affairs Bureau, MHW, Data should be attached in case of Application for manufacturing and import of orphan drug. June 29, 1985.
2. Hirai T, Urayama T. Intractable diseases and orphan drugs. Farumashia. 1995;31(7):770–778.
3. Shiragami M. Forefront of orphan drugs—Overview of orphan drugs development supporting system. Dispensing Drug Inf. 1999;5(7).
4. Medical Economics Division, Health Insurance Bureau, MHW ed. NHI Drug Price System. Tokyo: The Yakujinippo Limited; 1998;88.
5. Ueki A. Development promotion measure of orphan drugs newly introduced. Bio Tech. 1993;7:206.